Published in J Biol Chem on March 10, 2000
Mechanisms of apoptosis. Am J Pathol (2000) 3.23
Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension. EMBO J (2003) 2.70
Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survivin binding and phosphorylation. Mol Biol Cell (2002) 2.56
Cytokinesis in eukaryotes. Microbiol Mol Biol Rev (2002) 2.43
Human survivin is a kinetochore-associated passenger protein. J Cell Biol (2000) 2.21
A Bir1-Sli15 complex connects centromeres to microtubules and is required to sense kinetochore tension. Cell (2006) 1.79
Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biol (2001) 1.78
Sterilizing immunity in the lung relies on targeting fungal apoptosis-like programmed cell death. Science (2017) 1.40
The Schizosaccharomyces pombe aurora-related kinase Ark1 interacts with the inner centromere protein Pic1 and mediates chromosome segregation and cytokinesis. Mol Biol Cell (2002) 1.33
Uncoupling the central spindle-associated function of the chromosomal passenger complex from its role at centromeres. Mol Biol Cell (2006) 1.33
Identification of a novel chromosomal passenger complex and its unique localization during cytokinesis in Trypanosoma brucei. PLoS One (2008) 1.26
Inhibitor of apoptosis proteins in eukaryotic evolution and development: a model of thematic conservation. Dev Cell (2008) 1.21
Thymocyte-targeted overexpression of xiap transgene disrupts T lymphoid apoptosis and maturation. Proc Natl Acad Sci U S A (2001) 1.08
Phosphorylation of the chromosomal passenger protein Bir1 is required for localization of Ndc10 to the spindle during anaphase and full spindle elongation. Mol Biol Cell (2005) 1.03
A Bir1p Sli15p kinetochore passenger complex regulates septin organization during anaphase. Mol Biol Cell (2007) 0.97
Nbl1p: a Borealin/Dasra/CSC-1-like protein essential for Aurora/Ipl1 complex function and integrity in Saccharomyces cerevisiae. Mol Biol Cell (2009) 0.96
Human enhancer of invasion-cluster, a coiled-coil protein required for passage through mitosis. Mol Cell Biol (2004) 0.89
A comparison of programmed cell death between species. Genome Biol (2000) 0.87
Cellular and molecular effects of nonreciprocal chromosome translocations in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2008) 0.84
Increased Aurora B activity causes continuous disruption of kinetochore-microtubule attachments and spindle instability. Proc Natl Acad Sci U S A (2014) 0.83
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med (1997) 12.65
Control of apoptosis and mitotic spindle checkpoint by survivin. Nature (1998) 8.60
Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature (1986) 7.06
cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci U S A (1987) 4.61
Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol (1999) 4.11
Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res (1998) 3.63
Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci U S A (2000) 3.44
Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem (2000) 3.30
A family of receptors coupled to guanine nucleotide regulatory proteins. Biochemistry (1987) 2.91
Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J Neurosci (1997) 2.69
Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol (1998) 2.64
Transcriptional analysis of human survivin gene expression. Biochem J (1999) 2.39
Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res (1998) 2.38
Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem (1998) 2.27
Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood (2000) 2.23
Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell (1993) 2.22
Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dermatol (1999) 2.21
Delineation of the intronless nature of the genes for the human and hamster beta 2-adrenergic receptor and their putative promoter regions. J Biol Chem (1987) 2.20
Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol (2000) 2.10
Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet (1998) 2.08
Cancer gene therapy using a survivin mutant adenovirus. J Clin Invest (2001) 2.05
The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res (1999) 1.89
Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci U S A (2001) 1.89
Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene (2009) 1.87
Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem (1999) 1.82
Crystal structure and mutagenic analysis of the inhibitor-of-apoptosis protein survivin. Mol Cell (2000) 1.70
The a-factor transporter (STE6 gene product) and cell polarity in the yeast Saccharomyces cerevisiae. J Cell Biol (1993) 1.67
Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53. J Clin Invest (2001) 1.64
Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo. J Clin Invest (1997) 1.61
A point mutation in Galphao and Galphai1 blocks interaction with regulator of G protein signaling proteins. J Biol Chem (1998) 1.60
Regulation of survivin expression by IGF-1/mTOR signaling. Oncogene (2006) 1.59
Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med (1999) 1.58
Cytokine-regulated expression of survivin in myeloid leukemia. Blood (2001) 1.56
Expression and prognostic significance of survivin in de novo acute myeloid leukaemia. Br J Haematol (2000) 1.56
Endothelial cell activation by leukocyte microparticles. J Immunol (1998) 1.49
In vivo immunosuppression by targeting a novel protease receptor. Nature (1996) 1.42
Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc Natl Acad Sci U S A (1995) 1.39
Drug resistance in melanoma: mechanisms, apoptosis, and new potential therapeutic targets. Cancer Metastasis Rev (2001) 1.36
Sst2 is a GTPase-activating protein for Gpa1: purification and characterization of a cognate RGS-Galpha protein pair in yeast. Biochemistry (1998) 1.35
Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest (1999) 1.31
Control of yeast mating signal transduction by a mammalian beta 2-adrenergic receptor and Gs alpha subunit. Science (1990) 1.28
Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am J Pathol (2001) 1.27
Urine detection of survivin and diagnosis of bladder cancer. JAMA (2001) 1.23
Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging. J Biol Chem (1997) 1.23
Binding of fibrinogen to human monocytes. J Clin Invest (1986) 1.20
A functional analysis of a natural variant of intercellular adhesion molecule-1 (ICAM-1Kilifi). Hum Mol Genet (2000) 1.19
Differential ligand binding specificities of recombinant CD11b/CD18 integrin I-domain. J Biol Chem (1994) 1.18
Identification of Triton X-100 insoluble membrane domains in the yeast Saccharomyces cerevisiae. Lipid requirements for targeting of heterotrimeric G-protein subunits. J Biol Chem (1996) 1.16
Survivin does not inhibit caspase-3 activity. Blood (2000) 1.15
Selective uncoupling of RGS action by a single point mutation in the G protein alpha-subunit. J Biol Chem (1998) 1.15
Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis. Oncogene (2011) 1.13
Interleukin-11 up-regulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathway. Lab Invest (2001) 1.13
Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res (2003) 1.13
Regulation of membrane and subunit interactions by N-myristoylation of a G protein alpha subunit in yeast. J Biol Chem (1996) 1.12
Use of G-protein fusions to monitor integral membrane protein-protein interactions in yeast. Nat Biotechnol (2000) 1.10
Functional analysis of Plp1 and Plp2, two homologues of phosducin in yeast. J Biol Chem (2000) 1.07
Survivin expression in oral squamous cell carcinoma. Br J Cancer (2003) 1.06
Apical topography and modulation of ICAM-1 expression on activated endothelium. Am J Pathol (1995) 1.05
Feedback phosphorylation of an RGS protein by MAP kinase in yeast. J Biol Chem (1999) 1.02
Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa. J Biol Chem (1996) 0.99
Synthetic peptides of the hamster beta 2-adrenoceptor as substrates and inhibitors of the beta-adrenoceptor kinase. Br J Clin Pharmacol (1990) 0.98
High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5). J Biol Chem (1994) 0.97
Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease. Br J Cancer (2011) 0.97
miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression. Oncogene (2011) 0.96
A peptide derived from the intercellular adhesion molecule-2 regulates the avidity of the leukocyte integrins CD11b/CD18 and CD11c/CD18. J Cell Biol (1995) 0.96
Partial constitutive activation of pheromone responses by a palmitoylation-site mutant of a G protein alpha subunit in yeast. Biochemistry (1996) 0.95
The vascular E-selectin binds to the leukocyte integrins CD11/CD18. Glycobiology (1993) 0.94
Caspase 2-mediated tumor suppression involves survivin gene silencing. Oncogene (2009) 0.94
Fibrinogen mediates leukocyte-endothelium bridging in vivo at low shear forces. Blood (1996) 0.93
Activation-dependent exposure of the inter-EGF sequence Leu83-Leu88 in factor Xa mediates ligand binding to effector cell protease receptor-1. J Biol Chem (1997) 0.93
Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol (2001) 0.93
Systems biology analysis of G protein and MAP kinase signaling in yeast. Oncogene (2007) 0.93
Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones. Oncogene (2009) 0.92
Hormone signal response system. Nature (1993) 0.92
Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation. Biochem J (1996) 0.88
Dual regulation of ligand binding by CD11b I domain. Inhibition of intercellular adhesion and monocyte procoagulant activity by a factor X-derived peptide. J Biol Chem (1998) 0.88
Endoproteolytic processing of Sst2, a multidomain regulator of G protein signaling in yeast. J Biol Chem (2000) 0.88
Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling. Proc Natl Acad Sci U S A (1998) 0.88
Induction of ocular neoplasms in Fischer rats by intraocular injection of nickel subsulfide. Invest Ophthalmol Vis Sci (1982) 0.87
Second site suppressor mutations of a GTPase-deficient G-protein alpha-subunit. Selective inhibition of Gbeta gamma-mediated signaling. J Biol Chem (1998) 0.87
N-terminal domain of Gpa1 (G protein alpha) subunit) is sufficient for plasma membrane targeting in yeast Saccharomyces cerevisiae. J Cell Sci (1998) 0.85
Molecular dissection of effector cell protease receptor-1 recognition of factor Xa. Assignment of critical residues involved in antibody reactivity and ligand binding. J Biol Chem (1996) 0.84
Identification of novel pheromone-response regulators through systematic overexpression of 120 protein kinases in yeast. J Biol Chem (2001) 0.84
Cytokinesis, apoptosis and survivin: three for tango? Cell Death Differ (2001) 0.83
Thromboxane generation by human monocytes enhances platelet function. J Exp Med (1986) 0.81
Molecular biology of adrenergic receptors. Cold Spring Harb Symp Quant Biol (1988) 0.78
Animal models for the study of uveal melanoma. Int Ophthalmol Clin (1980) 0.77
AlphaMbeta2 (CD11b/CD18, Mac-1) integrin activation by a unique monoclonal antibody to alphaM I domain that is divalent cation-sensitive. J Leukoc Biol (2000) 0.77
Metastasis in a rabbit choroidal melanoma model. Invest Ophthalmol Vis Sci (1982) 0.77
Molecular identification of the cross-reacting epitope on alphaM beta2 integrin I domain recognized by anti-alphaIIb beta3 monoclonal antibody 7E3 and its involvement in leukocyte adherence. J Biol Chem (1998) 0.77
von Willebrand factor contaminating porcine factor VIII concentrate (Hyate:C) causes platelet aggregation. Br J Haematol (1986) 0.76
High affinity cross-reacting mAb generated by minimal mimicry: implications for the pathogenesis of anti-nuclear autoantibodies and immunosuppression. Proc Natl Acad Sci U S A (1998) 0.75
Protease receptors in Hodgkin's disease: expression of the factor Xa receptor, effector cell protease receptor-1, in Reed-Sternberg cells. Blood (1996) 0.75
Rapid assay of phage-derived recombinant human fabs as bispecific antibodies. Biotechnology (N Y) (1995) 0.75